This study aims to constitute a collection of biological materials from in transplant patients and to provide biological materials from transplanted patients in order :
i) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for rejection and other transplantation-related conditions (such as BK virus nephropathy, Post-transplant lymphoproliferative disorder ( PTLD) ...)
Male or Female patient ≥18 years old
Recipient of an organ transplant
Written informed consent
Non-affiliation to a social security system.
Subjects deprived of liberties
Pregnant or breastfeeding woman
All adult patients that received a solid organ transplant at the transplantation department of Lyon University Hospital
Cohort
Prospective
Biobank
Other interventionFor each patient included in the study the following samples will be collected at the indicated time points after transplantation: * Serum samples and plasma sample: Day1, Month 1, Month 3, Month 6, Month 12, month 60, month 120 and at the time of each allograft biopsy. * Urines samples: Month 3 and Month 12 and at the time of each allograft biopsy. * Peripheral Blood Mononuclear Cell (PBMC): for each organ allograft biopsy. * Allograft biopsies: systematically at Month 3, and Month 12, and for cause in case of allograft dysfunction.
the biological samples
The goal of this study is to provide biological materials from transplanted patients
Change Biological Samples
The goal of this study is to provide biological materials from transplanted patients
Change Biological Samples
The goal of this study is to provide biological materials from transplanted patients
Change Biological Samples
The goal of this study is to provide biological materials from transplanted patients
Click on the lead sponsor to view all of their trials.
